Navigation Links
Pharmaceutical Industry Service Company Awarded The UK's Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
Date:4/20/2012

LONDON, April 21, 2012 /PRNewswire/ --

Medaxial, the healthcare value communication specialist, today announces that it has won a Queen's Award for Enterprise in recognition of its international trade achievements.

The Queen's Awards for Enterprise are the UK's most prestigious business accolade, bestowed by Her Majesty Queen Elizabeth II on a select number of companies who have achieved outstanding results in international trade, innovation or sustainable development.  The awards are announced each year on April 21, The Queen's birthday.

Medaxial provides value communication solutions to many of the best-known names in the pharmaceutical, medical devices and diagnostics industries, and has been particularly successful in developing a client base in Europe and the USA.  The company's portfolio of services includes landscape and competitor assessment, clinical trial optimisation advice, pricing research, revenue forecasting, value message development and testing, strategic market access consultancy, health economic modelling, value dossier development, value communication toolkits and a wide range of tactical sales tools.  

Reacting to the news, one of the founding directors of Medaxial, John Fanshawe, said, "We have always believed that Medaxial's unique value communication perspective helps our clients to prosper in what are very difficult market conditions.  With continued pressure on healthcare budgets and the ever-increasing cost of bringing products to market, most pharmaceutical, biotechnology and medical devices companies now recognise the critical importance of successfully communicating the value of their products to the stakeholders who are expected to pay for them.  We have remained faithful to our belief in the central importance of value communication, and have built a reputation within the global healthcare industry for combining a rigorous approach to science and health economics with world-class communication expertise."

Paul Mcloughlin, also a founding director, added, "As a British company competing against some major overseas players, we operate in a tough and unforgiving marketplace, so we are absolutely delighted to receive this recognition.  Our growth over recent years is a testament to our understanding of the healthcare industry and the issues it faces, our insight into the decision-making processes in global healthcare systems, and the innovative value communication solutions that we provide."

About Medaxial

Medaxial is a specialist value communication consultancy with more than 15 years' experience of serving the global healthcare industry.  The services the company offers are based on two core beliefs: First, that no activity is more important to innovative healthcare companies than the communication of product value; and second, that value communication is inextricably linked to pricing, reimbursement, stakeholder research, health economic research and clinical evidence generation.

Medaxial is the only consultancy specialising in value communication that offers health economic, pricing and market access services. The company's value communication perspective ensures that all activities are focused on the central task of communicating product value in order to optimise commercial success.

The result is a highly-focused portfolio of services that helps clients demonstrate the value of innovative medicines, medical devices and diagnostic technologies, based on robust scientific evidence and high-quality market research.  

Medaxial is headquartered in London, England, and has an office in New York City serving the North American marketplace.  

About the Queen's Awards

Click this link for more information about The Queen's Awards



'/>"/>
SOURCE Medaxial
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology:
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... ... Haute Living, is proud to recognize Dr. Barry M. Weintraub as a prominent ... “the most beautiful women in the world, and the most handsome men, look ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group ... Tournament held on June 20th at the Woodmont Country Club at 1201 Rockville ... an organization dedicated to helping service members that have been wounded in battle and ...
Breaking Medicine News(10 mins):